eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | neurofibromatosis |
| Symptom | C0751690|malignant peripheral nerve sheath tumors |
| Sentences | 8 |
| PubMedID- 23242059 | Comparative effectiveness of 18f-fdg pet/ct versus whole-body mri for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1. |
| PubMedID- 20686424 | The role of angiogenesis in the transformation of plexiform neurofibroma into malignant peripheral nerve sheath tumors in children with neurofibromatosis type 1. |
| PubMedID- 21731277 | Intraoral presentation of multiple malignant peripheral nerve sheath tumors associated with neurofibromatosis-1. |
| PubMedID- 20664435 | Conclusion: neurofibromatosis type 1 with malignant peripheral nerve sheath tumors complicating pregnancy requires an experienced, multidisciplinary team of care offering an aggressive evaluation to rule out malignant transformation or recurrence when there is any change in clinical status of a patient, as this may signal a potentially fatal change in the lesion. |
| PubMedID- 23244685 | Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1. |
| PubMedID- 23101443 | Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1. |
| PubMedID- 23292448 | Since the bi-allelic inactivation of both neurofibromin 1 (nf1) gene alleles (nf1(-/-)) in schwann cells (scs) is common in both benign plexiform neurofibromas (pns) and malignant peripheral nerve sheath tumors (mpnsts) in patients with neurofibromatosis type 1 (nf1), other genetic alterations in scs may be required for tumor progression of pns to mpnsts. |
| PubMedID- 24166582 | Benign whole body tumor volume is a risk factor for malignant peripheral nerve sheath tumors in neurofibromatosis type 1. |
Page: 1